Read on for updates across the Research we Enable Postmortem Tissue (PMT) Core The Target ALS Postmortem Core has now ...

Invested in Biomarker Innovation ALS is a heterogeneous disease with distinct subpopulations of cases clustering together based on common underlying biology and with distinct differences in the ...

The Target ALS Global Natural History Study (GNHS) is entering a new phase of discovery. As the only international, ...

Predicting Phenoconversion in Carriers of ALS Pathogenic Variants People carrying mutations known to cause ALS make up at ...

Today, we mourn the loss of Brooke Eby. Brooke was a powerhouse. Witty, clever, joyful, and direct. She was unwilling to be ...

ALS (amyotrophic lateral sclerosis) is a disease that moves differently for everyone, but no one should have to face it ...

ALS is a disease of the motor neurons. However, emerging research from Target ALS-funded scientists is revealing that it’s not that simple; there’s a complex breakdown involving the immune system, ...

Tiffany Kindred leads mission-focused communications at Target ALS, translating complex research into accessible, compelling stories that help people understand the organization’s work and impact. She ...

Stephanie Ishoo drives Target ALS’s marketing and communications strategy to amplify the organization’s mission, promote participation in its research initiatives, and garner support. She brings over ...

This content is password-protected. To view it, please enter the password below.